Skip to main content
Download PDF
  • Retraction Note
  • Open access
  • Published:

Retraction Note: Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B

BMC Gastroenterology volume 22, Article number: 402 (2022) Cite this article

The Original Article was published on 10 May 2022

Retraction to: BMC Gastroenterology (2022) 22:228 https://doi.org/10.1186/s12876-022-02317-7

The authors have retracted this article as it has been published previously [1]. All authors agree with this retraction.

Reference

  1. Su P-Y, Yen H-H, Huang S-P, Hsu P-K, Chen Y-Y, Hsu Y-C. Switching from branded to generic entecavir in patients with treatment-naïve chronic hepatitis B: experience of a single tertiary medical center. Changhua J Med. 2021;19(4):P149–56. https://doi.org/10.6501/CJM.202112_19(4).0002.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan

    Po-Ke Hsu & Pei-Yuan Su

  2. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Po-Ke Hsu

  3. School of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Chia-Lin Wu

  4. Division of Nephrology, Changhua Christian Hospital, Changhua, Taiwan

    Chia-Lin Wu

  5. School of Medicine, National Chung Hsing University, Taichung, Taiwan

    Chia-Lin Wu

Authors
  1. Po-Ke Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pei-Yuan Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chia-Lin Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chia-Lin Wu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hsu, PK., Su, PY. & Wu, CL. Retraction Note: Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B. BMC Gastroenterol 22, 402 (2022). https://doi.org/10.1186/s12876-022-02483-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12876-022-02483-8

BMC Gastroenterology

ISSN: 1471-230X

Contact us